J&J/LifeScan To Exit Hospital Glucose Meter Market By 2013
Johnson & Johnson/LifeScan is exiting the hospital point-of-care blood glucose meter market in the U.S. and Canada to focus exclusively on consumer self-monitoring devices in the regions.
Johnson & Johnson/LifeScan is exiting the hospital point-of-care blood glucose meter market in the U.S. and Canada to focus exclusively on consumer self-monitoring devices in the regions.